Cited by 2,763Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 404 of the 409 references it cites were found in a registry or an index.

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Beaulieu, Jean-Martin, Gainetdinov, Raul R.·2011·Pharmacological Reviews

DOI 10.1124/pr.110.002642

Open this paper in CoChat — free account

Abstract

G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Pharmacological agents targeting dopaminergic neurotransmission have been clinically used in the management of several neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD(1)), and Tourette's syndrome. Numerous advances have occurred in understanding the general structural, biochemical, and functional properties of dopamine receptors that have led to the development of multiple pharmacologically active compounds that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics. Recent progress in understanding the complex biology of dopamine receptor-related signal transduction mechanisms has revealed that, in addition to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins. One of the future directions in managing dopamine-related pathologic conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacology. In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms. In addition, we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacology and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.

Integrity signals

Registry

Crossref · 10.1124/pr.110.002642

Cites

404 of 404 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,756
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Seven-transmembrane receptors
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220

Show all 409 references

Sorted by citations

Items 501–600 of 1,006

Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: Relevance as an animal model of mania
Macêdo, D. S., de Lucena, D. F., Queiroz, A. I. G., Cordeiro, R. C., Araújo, M. M., Sousa, F. C., Vasconcelos, S. M., Hyphantis, T. N., Quevedo, J., McIntyre, R. S., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.007 · Cited by 50
Increased Expression of Dopamine Receptors in Synovial Fibroblasts From Patients With Rheumatoid Arthritis: Inhibitory Effects of Dopamine on Interleukin‐8 and Interleukin‐6
Capellino, S., Cosentino, M., Luini, A., Bombelli, R., Lowin, T., Cutolo, M., Marino, F., & Straub, R. H. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38746 · Cited by 49
Time-Resolved FRET Binding Assay to Investigate Hetero-Oligomer Binding Properties: Proof of Concept with Dopamine D1/D3Heterodimer
Hounsou, C., Margathe, J., Oueslati, N., Belhocine, A., Dupuis, E., Thomas, C., Mann, A., Ilien, B., Rognan, D., Trinquet, E., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb5007568 · Cited by 49
Nanodiamonds on tetrahedral amorphous carbon significantly enhance dopamine detection and cell viability
Peltola, E., Wester, N., Holt, K. B., Johansson, L., Koskinen, J., Myllymäki, V., & Laurila, T. T. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.055 · Cited by 49
Gradient of Expression of Dopamine D2 Receptors Along the Dorso-Ventral Axis of the Hippocampus
Dubovyk, V., & Manahan‐Vaughan, D. (2019) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2019.00028 · Cited by 49
Dopamine Signaling in the Suprachiasmatic Nucleus Enables Weight Gain Associated with Hedonic Feeding
Grippo, R. M., Tang, Q., Zhang, Q., Chadwick, S. R., Gao, Y., Altherr, E. B., Sipe, L. M., Purohit, A. M., Purohit, N. M., Sunkara, M., et al. (2020) · Current Biology · doi:10.1016/j.cub.2019.11.029 · Cited by 49
Dopamine D2-Like Receptors Modulate Intrinsic Properties and Synaptic Transmission of Parvalbumin Interneurons in the Mouse Primary Motor Cortex
Cousineau, J., Lescouzères, L., Taupignon, A., Delgado-Zabalza, L., Valjent, E., Baufreton, J., & Bon-Jégo, M. L. (2020) · eNeuro · doi:10.1523/eneuro.0081-20.2020 · Cited by 50
Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets?
Rosas-Cruz, A., Salinas-Jazmín, N., & Velasco-Velázquez, M. A. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211027913 · Cited by 49
Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: Evidence from pharmacological analysis
Idova, G. V., Лазаревна, А. Е., & Чейдо, М. А. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.02.010 · Cited by 49
Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline
Lin, S., Leng, Z. G., Guo, Y., Cai, L., Cai, Y. C., Li, N., Shang, H. B., Le, W.-D., Zhao, W., & Wu, Z. B. (2015) · Oncotarget · doi:10.18632/oncotarget.5744 · Cited by 49
Pathophysiologic Role of Neurotransmitters in Digestive Diseases
Yang, X., Lou, J., Shan, W., Ding, J., Jin, Z., Hu, Y., Du, Q., Liao, Q., Xie, R., & Xu, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.567650 · Cited by 48
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
Battaglin, F., Jayachandran, P., Strelez, C., Lenz, A. M., Algaze, S. D., Soni, S., Lo, J. H., Yang, Y., Millstein, J., Zhang, W., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02479-4 · Cited by 48
Neurotransmitters and Neuropeptides: New Players in the Control of Islet of Langerhans' Cell Mass and Function
Cairano, E. S. D., Moretti, S., Marciani, P., Sacchi, V. F., Castagna, M., Davalli, A. M., Folli, F. B., & Perego, C. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25176 · Cited by 48
A Novel G Protein-Coupled Receptor of Schistosoma mansoni (SmGPR-3) Is Activated by Dopamine and Is Widely Expressed in the Nervous System
El-Shehabi, F., Taman, A. I., Moali, L. S., El‐Sakkary, N., & Ribeiro, P. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001523 · Cited by 48
Tetraspanin (TSP-17) Protects Dopaminergic Neurons against 6-OHDA-Induced Neurodegeneration in C. elegans
Masoudi, N., Ibanez-Cruceyra, P., Offenburger, S.-L., Holmes, A., & Gartner, A. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004767 · Cited by 48
Dopamine disruption increases negotiation for cooperative interactions in a fish
Messias, J. P. M., Paula, J. R., Grutter, A. S., Bshary, R., & Soares, M. C. (2016) · Scientific Reports · doi:10.1038/srep20817 · Cited by 50
Accelerated leukocyte telomere erosion in schizophrenia: Evidence from the present study and a meta-analysis
Rao, S., Kota, L. N., Li, Z., Yao, Y., Tang, J., Mao, C., Jain, S., Xu, Y. J., & Xu, Q. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.04.010 · Cited by 48
Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer’s Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
Jha, S. K., Jha, N. K., Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., & Kumar, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160623 · Cited by 48
Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R)
Kumar, V., Moritz, A. E., Keck, T. M., Bonifazi, A., Ellenberger, M. P., Sibley, C. D., Free, R. B., Shi, L., Lane, J. R., Sibley, D. R., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01688 · Cited by 48
Dopamine terminals from the ventral tegmental area gate intrinsic inhibition in the prefrontal cortex
Buchta, W. C., Mahler, S. V., Harlan, B. A., Aston‐Jones, G., & Riegel, A. C. (2017) · Physiological Reports · doi:10.14814/phy2.13198 · Cited by 48
Chronic Social Isolation Stress during Peri-Adolescence Alters Presynaptic Dopamine Terminal Dynamics via Augmentation in Accumbal Dopamine Availability
Karkhanis, A. N., Leach, A. C., Yorgason, J. T., Uneri, A., Barth, S. H., Niere, F., Alexander, N. J., Weiner, J. L., McCool, B. A., Raab‐Graham, K. F., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00360 · Cited by 48
Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges
Runegaard, A. H., Fitzpatrick, C. M., Woldbye, D. P. D., Andreasen, J. T., Sørensen, A. T., & Gether, U. (2019) · Pharmacological Reviews · doi:10.1124/pr.117.013995 · Cited by 48
Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection
Ortiz‐Guerrero, G., González-Reyes, R. E., de‐la‐Torre, A., Medina-Rincón, G. J., & Nava-Mesa, M. O. (2020) · Brain Sciences · doi:10.3390/brainsci10060369 · Cited by 48
Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
Magistrelli, L., Ferrari, M., Furgiuele, A., Milner, A. V., Contaldi, E., Comi, C., Cosentino, M., & Marino, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073781 · Cited by 48
Aptamer biosensor for dopamine based on a gold electrode modified with carbon nanoparticles and thionine labeled gold nanoparticles as probe
Xu, Y., Hun, X., Liu, F., Wen, X., & Luo, X. (2015) · Microchimica Acta · doi:10.1007/s00604-015-1509-5 · Cited by 48
The dopaminergic system and Alzheimer’s disease
Zhang, Y., Liang, Y., & Gu, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00230 · Cited by 47
Noradrenalin and dopamine receptors both control cAMP-PKA signaling throughout the cerebral cortex
Nomura, S., Bouhadana, M., Morel, C., Fauré, P., Cauli, B., Lambolez, B., & Hepp, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00247 · Cited by 47
Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice
Pötschke, C., Dragicevic, E., Duda, J., Benkert, J., Dougalis, A., Zio, R. D., Snutch, T. P., Striessnig, J., & Liss, B. (2015) · Scientific Reports · doi:10.1038/srep13688 · Cited by 47
Pharmacological analysis of zebrafish lphn3.1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity
Lange, M., Froc, C., Grunwald, H. A., Norton, W., & Bally‐Cuif, L. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.010 · Cited by 47
Reversal of Vasodilatory Shock: Current Perspectives on Conventional, Rescue, and Emerging Vasoactive Agents for the Treatment of Shock
Chow, J. H., Abuelkasem, E., Sankova, S. K., Henderson, R. A., Mazzeffi, M. A., & Tanaka, K. A. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004343 · Cited by 47
The potential roles of dopamine in traumatic brain injury: a preclinical and clinical update.
Lan, Y., Li, S., Lou, J., Ma, X., & Zhang, B. (2019) · PubMed Central · Cited by 47
The Distinct Functions of Dopaminergic Receptors on Pain Modulation: A Narrative Review
Wang, X., Mokhtari, T., Zeng, Y., Yue, L., & Hu, L. (2021) · Neural Plasticity · doi:10.1155/2021/6682275 · Cited by 47
Ligand-directed bias of G protein signaling at the dopamine D2 receptor
Moo, E. V., Harpsøe, K., Hauser, A. S., Masuho, I., Bräuner‐Osborne, H., Gloriam, D. E. I., & Martemyanov, K. A. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.07.004 · Cited by 47
Antioxidative role of Traditional Chinese Medicine in Parkinson's disease
Muhammad, F., Liu, Y., Zhou, Y., Yang, H., & Li, H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114821 · Cited by 47
Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and phasic dopamine signaling
Dreyer, J. K., & Hounsgaard, J. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00502.2012 · Cited by 47
Effect of Maternal Lipopolysaccharide Administration on the Development of Dopaminergic Receptors and Transporter in the Rat Offspring
Baharnoori, M., Bhardwaj, S. K., & Srivastava, L. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054439 · Cited by 47
Prevalence and Treatment Outcomes of Persistent Negative Mood Among Children with Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior
Blader, J. C., Pliszka, S. R., Kafantaris, V., Sauder, C. L., Posner, J. E., Foley, C. A., Carlson, G. A., Crowell, J. A., & Margulies, D. M. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0112 · Cited by 47
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis
Svensson, K. A., Heinz, B. A., Schaus, J. M., Beck, J. P., Hao, J., Krushinski, J. H., Reinhard, M. R., Cohen, M. P., Hellman, S. L., Getman, B. G., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.236372 · Cited by 47
Dopamine Receptor Activation Modulates the Integrity of the Perisynaptic Extracellular Matrix at Excitatory Synapses
Mitlöhner, J., Kaushik, R., Niekisch, H., Blondiaux, A., Gee, C. E., Happel, M. F. K., Gundelfinger, E., Dityatev, A., Frischknecht, R., & Seidenbecher, C. (2020) · Cells · doi:10.3390/cells9020260 · Cited by 47
The effects of early life stress on impulsivity
Sanchez, E. O., & Bangasser, D. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104638 · Cited by 46
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease
Hajj, R., Milet, A., Toulorge, D., Cholet, N., Laffaire, J., Foucquier, J., Robelet, S., Mitry, R., Guedj, M., Nabirotchkin, S., et al. (2015) · Scientific Reports · doi:10.1038/srep16084 · Cited by 46
Chronic D2/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns
Tremblay, M., Silveira, M. M., Kaur, S., Hosking, J. G., Adams, W. K., Baunez, C., & Winstanley, C. A. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13332 · Cited by 46
The neurocircuitry involved in oxytocin modulation of methamphetamine addiction
Baracz, S. J., & Cornish, J. L. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.08.001 · Cited by 46
The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons
Rapanelli, M., Frick, L. R., Horn, K. D., Schwarcz, R. C., Pogorelov, V. M., Nairn, A. C., & Pittenger, C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731406 · Cited by 46
THE INTRIGUING LIGAND-DEPENDENT AND LIGAND-INDEPENDENT ACTIONS OF THE GROWTH HORMONE SECRETAGOGUE RECEPTOR ON REWARD-RELATED BEHAVIORS
Cornejo, M. P., Mustafá, E. R., Barrile, F., Cassano, D., Francesco, P. N. D., Raingo, J., & Perelló, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.017 · Cited by 46
The Role of CaMKII and ERK Signaling in Addiction
Jia, W., Kawahata, K., Cheng, A., & Fukunaga, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063189 · Cited by 44
Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy
Cosentino, M., Zaffaroni, M., Trojano, M., Giorelli, M., Pica, C., Rasini, E., Bombelli, R., Ferrari, M., Ghezzi, A., Comi, G., et al. (2012) · NeuroImmunoModulation · doi:10.1159/000336981 · Cited by 45
Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease
Francelle, L., Galvan, L., & Brouillet, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00295 · Cited by 45
Serotonin and catecholamines in the development and progression of heart valve diseases
Goldberg, E., Grau, J. B., Fortier, J. H., Salvati, E., Levy, R. J., & Ferrari, G. M. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx092 · Cited by 45
Common mental disorders and association with telomere length (Review)
Vakonaki, E., Tsiminikaki, K., Plaitis, S., Fragkiadaki, P., Tsoukalas, D., Katsikantami, I., Vaki, G., Tzatzarakis, M., Spandidos, D. A., & Tsatsakis, A. M. (2018) · Biomedical Reports · doi:10.3892/br.2018.1040 · Cited by 45
Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment
Huang, X., & Song, X. (2018) · Medicinal Research Reviews · doi:10.1002/med.21512 · Cited by 45
Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites
Luderman, K. D., Conroy, J., Free, R. B., Southall, N. T., Ferrer, M., Sánchez‐Soto, M., Moritz, A. E., Willette, B. K. A., Fyfe, T. J., Jain, P., et al. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113175 · Cited by 45
Assessment of the endocrine-disrupting effects of organophosphorus pesticide triazophos and its metabolites on endocrine hormones biosynthesis, transport and receptor binding in silico
Yang, F., Li, Y., Ren, F., Luo, J., & Pang, G. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110759 · Cited by 45
Dopamine D1 Receptor in Cancer
Sobczuk, P., Łomiak, M., & Cudnoch‐Jędrzejewska, A. (2020) · Cancers · doi:10.3390/cancers12113232 · Cited by 45
Cholinergic and dopaminergic effects on prediction error and uncertainty responses during sensory associative learning
Iglesias, S., Kasper, L., Harrison, S. J., Manka, R., Mathys, C. D., & Stephan, K. E. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117590 · Cited by 45
Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease
Nayeri, T., Sarvi, S., Sharif, M., & Daryani, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07151 · Cited by 46
Dopaminergic Control of Long-Term Depression/Long-Term Potentiation Threshold in Prefrontal Cortex
Sheynikhovich, D., Otani, S., & Arleo, A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0466-13.2013 · Cited by 45
Neurobiology of Aggression—Review of Recent Findings and Relationship with Alcohol and Trauma
Fritz, M., Soravia, S.-M., Dudeck, M., Malli, L., & Fakhoury, M. (2023) · Biology · doi:10.3390/biology12030469 · Cited by 44
Arresting the Development of Addiction: The Role of β-Arrestin 2 in Drug Abuse
Porter‐Stransky, K. A., & Weinshenker, D. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240622 · Cited by 44
Photochromic Dopamine Receptor Ligands Based on Dithienylethenes and Fulgides
Lachmann, D., Studte, C., Männel, B., Hübner, H., Gmeiner, P., & König, B. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201702147 · Cited by 44
Dopamine 2 Receptor Activation Entrains Circadian Clocks in Mouse Retinal Pigment Epithelium
Baba, K., DeBruyne, J. P., & Tosini, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-05394-x · Cited by 44
Striatal dopaminergic alterations in Tourette’s syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies
Hienert, M., Gryglewski, G., Stamenkovic, M., Kasper, S. F., & Lanzenberger, R. R. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0202-y · Cited by 44
TP10-Dopamine Conjugate as a Potential Therapeutic Agent in the Treatment of Parkinson’s Disease
Rusiecka, I., Ruczyński, J., Kozłowska, A., Backtrog, E., Mucha, P., Kocić, I., & Rekowski, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00894 · Cited by 44
Neurochemical and molecular mechanisms underlying the retrieval-extinction effect
Cahill, E., & Milton, A. L. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5121-3 · Cited by 44
Dopamine D2 receptor modulates Wnt expression and control of cell proliferation
Han, F., Konkalmatt, P. R., Mokashi, C. S., Kumar, M., Zhang, Y., Ko, A., Farino, Z. J., Asico, L. D., Xu, G., Gildea, J. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52528-4 · Cited by 44
D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice
Tang, D., Luan, Y., Zhou, C., & Xiao, C. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0433-3 · Cited by 44
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior
Spada, A., Mantovani, G., Lania, A. G., Treppiedi, D., Mangili, F., Catalano, R., Carosi, G., Sala, E., & Peverelli, E. (2021) · Neuroendocrinology · doi:10.1159/000514862 · Cited by 44
Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
Matteoni, S., Matarrese, P., Ascione, B., Buccarelli, M., Ricci‐Vitiani, L., Pallini, R., Villani, V., Pace, A., Paggi, M. G., & Abbruzzese, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.635472 · Cited by 44
The Neurobiology of Bipolar Disorder
Young, A. H., & Juruena, M. F. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_179 · Cited by 44
Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice
Vijeepallam, K., Pandy, V., Kunasegaran, T., Murugan, D. D., & Naidu, M. K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00464 · Cited by 44
Modulating cell signalling in vivo with magnetic nanotransducers
Romero, G., Park, J., Koehler, F., Pralle, A., & Anikeeva, P. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00170-2 · Cited by 46
Genetically Encoded Sensors for the In Vivo Detection of Neurochemical Dynamics
Yang, Y., Li, B., & Li, Y. (2024) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061522-044819 · Cited by 41
Surface-Enhanced Raman Scattering Nanosensing and Imaging in Neuroscience
Boudries, R., Williams, H., Paquereau--Gaboreau, S., Bashir, S., Jodaylami, M. H., Chisanga, M., Trudeau, L., & Masson, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c05200 · Cited by 43
Effects of Enteral Nutrition on the Barrier Function of the Intestinal Mucosa and Dopamine Receptor Expression in Rats With Traumatic Brain Injury
Zhang, X., & Jiang, X. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113501881 · Cited by 43
SLC10A4 Is a Vesicular Amine-Associated Transporter Modulating Dopamine Homeostasis
Larhammar, M., Patra, K., Blunder, M., Emilsson, L., Peuckert, C., Arvidsson, E., Rönnlund, D., Preobraschenski, J., Birgner, C., Limbach, C., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.017 · Cited by 43
Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs
Nash, A. I. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.07.010 · Cited by 43
Looking into the brain through the retinal ganglion cells in psychiatric disorders: A review of evidences
Schwitzer, T., Schwan, R., Bubl, E., Lalanne, L., Angioï-Duprez, K., & Laprévote, V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.008 · Cited by 43
Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor
Free, R. B., Cuoco, C. A., Xie, B., Namkung, Y., Prabhu, V. V., Willette, B. K. A., Day, M. M., Sánchez‐Soto, M., Lane, J. R., Laporte, S. A., et al. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000336 · Cited by 43
Dopamine signaling regulates hematopoietic stem and progenitor cell function
Liu, Y., Chen, Q., Jeong, H., Han, D., Fabian, J., Drexler, H. C. A., Stehling, M., Schöler, H. R., & Adams, R. H. (2021) · Blood · doi:10.1182/blood.2020010419 · Cited by 43
Characterization of extrastriatal D2 in vivo specific binding of [18F](N‐methyl)benperidol using PET
Eisenstein, S. A., Koller, J. M., Piccirillo, M. L., Kim, A., Antenor‐Dorsey, J. A. V., Videen, T. O., Snyder, A. Z., Karimi, M., Moerlein, S. M., BLACK, K. J., et al. (2012) · Synapse · doi:10.1002/syn.21566 · Cited by 43
Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease
Das, B., Vedachalam, S., Luo, D., Antonio, T., Reith, M. E. A., & Dutta, A. K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01031 · Cited by 43
Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis
Sarkar, C., Ganju, R. K., Pompili, V. J., & Chakroborty, D. (2016) · Angiogenesis · doi:10.1007/s10456-016-9531-8 · Cited by 42
Developing an electrochemical sensor for the in vivo measurements of dopamine
Delmo, N., Mostafiz, B., Ross, A. E., Suni, J., & Peltola, E. (2023) · Sensors & Diagnostics · doi:10.1039/d2sd00230b · Cited by 42
New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists
Peng, A., Chai, J., Wu, H., Bai, B., Yang, H., He, W., & Zhao, Y. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s455279 · Cited by 42
Alcohol intake enhances glutamatergic transmission from D2 receptor-expressing afferents onto D1 receptor-expressing medium spiny neurons in the dorsomedial striatum
Lu, J., Cheng, Y., Wang, X., Woodson, K., Kemper, W. C., Disney, E., & Wang, J. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0332-9 · Cited by 42
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions
Melnikov, M., Rogovskii, V., Boyко, A., & Pashenkov, M. V. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09852-3 · Cited by 42
The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D 3 Receptor (D 3 R) Selective Agonists
Battiti, F. O., Cemaj, S., Guerrero, A. M., Shaik, A. B., Lam, J., Rais, R., Slusher, B. S., Deschamps, J. R., Imler, G. H., Newman, A. H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00702 · Cited by 42
The Fat Mass and Obesity-Associated Protein (FTO) Regulates Locomotor Responses to Novelty via D2R Medium Spiny Neurons
Ruud, J., Alber, J., Tokarska, A., Engström, L., Nolte, H., Biglari, N., Lippert, R. N., Lautenschlager, Ä., Cieślak, P. E., Szumiec, Ł., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.037 · Cited by 42
HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System
Nickoloff-Bybel, E. A., Calderon, T. M., Gaskill, P. J., & Berman, J. W. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09927-6 · Cited by 42
Stimulation of the D5 dopamine receptor acidifies the lysosomal pH of retinal pigmented epithelial cells and decreases accumulation of autofluorescent photoreceptor debris
Guha, S., Baltazar, G. C., Tu, L., Liu, J., Lim, J. C.-S., Lu, W., Argall, A. J., Boesze‐Battaglia, K., Laties, A. M., & Mitchell, C. H. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07804.x · Cited by 44
Dopaminergic therapies modulate the T‐CELL proteome of patients with Parkinson's disease
Alberio, T., Pippione, A. C., Comi, C., Olgiati, S., Cecconi, D., Zibetti, M., Lopiano, L., & Fasano, M. (2012) · IUBMB Life · doi:10.1002/iub.1073 · Cited by 42
Are dopamine D2 receptors out of control in psychosis?
Seeman, P. M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.006 · Cited by 42
Dopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway
Robinson, S. E., & Sohal, V. S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1893-17.2017 · Cited by 42
Structural insights into G protein activation by D1 dopamine receptor
Teng, X., Chen, S., Wang, Q., Chen, Z., Wang, X., Huang, N., & Zheng, S. (2022) · Science Advances · doi:10.1126/sciadv.abo4158 · Cited by 41
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5
Jeon, H.-M., Oh, Y. T., Shin, Y. J., Chang, N., Kim, D., Woo, D., Yeup, Y., Joo, K. M., Jo, H., Yang, H., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100894 · Cited by 41
The nucleus accumbens shell: a neural hub at the interface of homeostatic and hedonic feeding
Marinescu, A., & Labouesse, M. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1437210 · Cited by 41
Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations
Ringel, L., Basken, J. N., Grant, L. M., & Ciucci, M. R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.006 · Cited by 41
Homobivalent Ligands of the Atypical Antipsychotic Clozapine: Design, Synthesis, and Pharmacological Evaluation
McRobb, F. M., Crosby, I. T., Yuriev, E., Lane, J. R., & Capuano, B. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201420s · Cited by 41
2,3,9- and 2,3,11-Trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands
Párraga, J., Cabedo, N., Andújar, S. A., Piqueras, L., Moreno, L., Galán, A., Angelina, E., Enriz, R. D., Ivorra, M. D., Sanz, M., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.07.036 · Cited by 41
Oligomerization of GPCRs involved in endocrine regulation
Kleinau, G., Müller, A., & Biebermann, H. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0049 · Cited by 41

Authors: Beaulieu, J.-M., & Gainetdinov, R. R.
Affiliations: Université Laval (CA)
Italian Institute of Technology (IT)
ORCID: Beaulieu, Jean-Martin
Gainetdinov, Raul R.
Venue: Pharmacological Reviews
Publisher: Elsevier BV
Published: 2011-03
Volume: 63
Issue: 1
Pages: 182-217
ISSN: 0031-6997 (ISSN-L)
DOI: 10.1124/pr.110.002642
OpenAlex: W2097744565
Cited by: 2,763
References: 409
Citations by year: 2026: 157 · 2025: 183 · 2024: 172 · 2023: 193 · 2022: 201 · 2021: 197 · 2020: 198 · 2019: 220 · 2018: 200 · 2017: 187 · 2016: 205 · 2015: 175 · 2014: 194 · 2013: 136 · 2012: 101
FWCI: 13.93
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacological Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research (NSA93798)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: dopamine receptors, dopamine D1/D5 receptors, G protein-coupled receptors, signal transduction, cAMP signaling, G protein-independent signaling, beta-arrestin, receptor desensitization, antiparkinsonian drugs, antipsychotic drugs
MeSH terms: Animals, Gene Expression Regulation, Humans, Ligands, Receptors, Dopamine, Signal Transduction, Dopamine Agonists, Dopamine Antagonists, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks